Alaunos Therapeutics | ZIOP - Przychody Ze Sprzedaży





Obroty Zmiana Data
Alaunos Therapeutics USD 2K 2K 2025-03
Amgen USD 10.1B 1.48B 2026-06
AstraZeneca USD 15.38B 90M 2026-06
Baxter International USD 2.96B 260M 2026-06
Biogen USD 2.74B 490M 2026-06
Bioline Rx USD 477K 283K 2026-03
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Celltrion KRW 1.24T 90B 2026-06
Corcept Therapeutics USD 256.15M 91.25M 2026-06
Cspc Pharmaceutical CNY 6.47B 355.1M 2026-03
Curis USD 1.14M 1.41M 2025-12
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 27.58B 730M 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
GlaxoSmithKline GBP 8.41B 781M 2026-06
Incyte USD 1.67B 400M 2026-06
Intrexon USD 717K 511K 2024-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
J&J USD 25.31B 1.21B 2026-06
Kangmei Pharma CNY 1.08B 288.27M 2026-03
Karyopharm Therapeutics USD 35.07M 987K 2026-03
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Merck USD 16.6B 310M 2026-06
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Novartis USD 14.41B 1.3B 2026-06
Organigram Holdings CAD 59.79M 3.74M 2026-03
Pfizer USD 15.03B 530M 2026-06
Pharma Mar EUR 50M 7.1M 2026-06
PTC Therapeutics USD 361M 88M 2026-06
Qiagen NV USD 463.12M 43.9M 2026-06
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Sartorius EUR 911.8M 12.7M 2026-06
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
TG Therapeutics USD 240.34M 45.54M 2026-06
Tilray USD 217.51M 74.75M 2025-12
Verastem USD 18.67M 1.14M 2026-03
Zealand Pharma A/S 34M 34.92M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M 2026-03